MiR‐129–1, as a negative regulator of IGF2BP3 and MAPK1, participates in cell cycle arrest in glioblastoma and acts as a potential tumor suppressor (Kouhkan et al., 2016). The gene discussed is MAPK1; the disease is neoplasm.